Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823
Cancer Vaccines01:30

Cancer Vaccines

319
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
319

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Recent Advances in Direct Single Oxygen Atom Insertion Into Organic Frameworks.

Chemistry, an Asian journal·2026
Same author

An Implantable Phototriggered Prodrug Depot Patch Enables Actively Programmable Drug Release for Post-Myocardial Infarction Therapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Lipopolysaccharide hydrolysis-targeting nano-chimeras detoxify endotoxin through specific adsorption and efficient degradation.

Nature communications·2026
Same author

Emerging Progress of walnut protein: A critical review on structural characterization, functional optimization, and application expansion.

Food chemistry·2026
Same author

Delivering living medicines with polysaccharide derivatives for disease treatment.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

High-throughput phenotyping for climate-resilient forests: integrating multi-sensor fusion and root-shoot dynamics.

Frontiers in plant science·2026

相关实验视频

Updated: May 22, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.1K

一种诱导热的自剂,用于激活抗癌免疫力.

Yanjie Li1,2,3,4,5,6, Hanxin Feng1,2,3,4,5,6, Huang Yang1,7

  • 1Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.

Advanced healthcare materials
|March 12, 2025
PubMed
概括

这项研究介绍了MnNZ@OMV,这是一种新型药物,可以有效地在瘤细胞中触发激素灭绝. 这种方法通过激活免疫细胞和促进癌症免疫疗法来增强抗瘤免疫力.

关键词:
抗癌免疫力 抗癌免疫力这是一个纳米酶纳米酶.在外膜囊泡中,外膜囊泡热致灭 (pyroptosis) 是一种致的过程.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.5K

相关实验视频

Last Updated: May 22, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.1K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.5K

科学领域:

  • 生物技术是生物技术.
  • 免疫学 免疫学 免疫学
  • 材料科学 材料科学 材料科学

背景情况:

  • 作为一个被编程的细胞死亡途径,热亡是抗瘤免疫力的有希望的策略.
  • 由于caspase激活有限,在瘤细胞中有效诱导热的存在挑战.

研究的目的:

  • 为增强抗瘤免疫力开发一种自启动的激素灭亡诱导剂 (MnNZ@OMV).
  • 通过非正规的caspase-11/GSDMD通路调查MnNZ@OMV诱导的热的机制.

主要方法:

  • 外膜囊泡 (OMV) 与二氧化纳米酶 (MnNZ) 的集成,以产生 MnNZ@OMV.
  • 在体外和体内研究评估MnZ@OMV诱导热的能力,耗尽谷氨,产生活性氧物种,并激活免疫细胞.

主要成果:

  • MnNZ@OMV通过对细胞内谷氨 (GSH) 的反应,有效地诱导瘤细胞中的灭.
  • 该药物触发NF-κB转位,原始化caspase-11表达,并导致GSDMD裂变.
  • 在体内研究表明MnNZ@OMV能够促进树突细胞成熟和CD8+T细胞激活,从而产生显著的抗瘤作用.

结论:

  • 成功开发了一种新型的自启动性热诱导剂 (MnNZ@OMV).
  • 这种方法利用非正规的caspase-11/GSDMD途径来诱导瘤细胞的烧灭.
  • MnNZ@OMV显示出作为癌症免疫疗法的治疗策略的巨大潜力.